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Introduction	
	
The	Opioid	Epidemic	A	fire	has	started	in	our	healthcare	system,	burning	across	America.	The	Opioid	Epidemic,	feared	as	the	most	unstable	and	unstoppable	health	crisis	throughout	America,	has	revealed	concerning	statistics	involving	addicts	and	abusers	(Kolodney	et	al,	2015).	The	National	Institute	on	Drug	Abuse	reports	that	21	to	29	percent	of	patients	prescribed	opioids	develop	an	addiction	to	them	(Diez	Roux,	2017).	In	2015,	more	than	33,000	people	died	due	to	opioid	overdoses.	That	same	year,	2	million	patients	suffering	from	substance	use	disorders	were	primary	users	of	opioids.	As	every	year	passes,	the	casualties	to	this	Epidemic	increase	with	little	to	no	sign	of	stopping	(Rudd,	2016).		To	make	matters	worse,	the	most	recent	calculation	by	the	NDI	indicates	that	47,800	people	died	of	opioid	overdose	in	2017.	This	means	that	in	two	years,	the	number	of	mortalities	due	to	opioid	overdose	increased	by	almost	50%.	If	extrapolated	for	the	next	two	years,	if	the	epidemic	continues	at	the	same	rate,	opioid	overdosage	will	cause	almost	72,000	deaths	in	2019.	For	perspective,	updated	statistics	reported	by	the	CDC	estimate	the	combined	deaths	of	motor	vehicle	accidents	and	gun	violence	rests	at	71,673.	For	further	understanding,	opioid	overdose,	if	the	population	of	opioid	abuser	continues	at	the	same	rate	as	the	past	4	years,	would	be	the	eighth	largest	cause	of	death	in	the	United	States,	between	diabetes	and	influenza/pneumonia.	By	the	numbers	alone,	the	Opioid	
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Epidemic	rests	its	case	as	an	extremely	crucial	clinical	issue	to	handle	that	continues	to	rise	rapidly	through	the	ranks	of	fatal	conditions	afflicting	this	country.	
The	Epidemic	itself	has	crossed	borders,	with	a	study	of	Emergency	Departments	in	Alberta,	Canada	reporting	a	57.3%	increase	in	patients	with	opioid	abuse	(Moe	et	al,	2018).	Evidence	also	demonstrates	that	opioid	users	have	a	high	risk	of	transitioning	to	less	stable	and	more	unregulated	drugs	such	as	heroin	and	fentanyl	(Dasgupta	et	al,	2017).	Considering	that	as	of	2017,	the	combined	fatalities	from	overdose	on	illicit	drugs	and	opioids	already	exceeded	72,00,	the	current	projection	of	fatalities	for	2019	overtakes	Alzheimer’s	diseases	as	the	sixth	leading	cause	of	U.S.	deaths.	Ultimately,	the	American	healthcare	system	is	struggling	to	find	a	solution	to	the	Opioid	Epidemic,	and	until	effective	systems	are	in	place,	the	rates	of	opioid	addicts	and	overdoses	will	continue	to	rise	(Nelson	et	al,	2015).		With	a	demographic	as	afflicted	as	people	suffering	from	opioid	abuse,	a	huge	clinic	need	and	burden	follows	(Machikanti	et	al,	2012).	Current	interventional	methods	are	considered	expensive	and	largely	ineffective	(Sahota	et	al,	2018).	Of	the	1555	articles	searched	and	analyzed	by	Sahota	and	her	team	only	found	6	to	provide	measurements	that	qualified	for	evaluation.	None	of	these	six	actual	produced	results	that	were	statistically	significant	or	valid.	In	2007,	it	was	estimated	that	opioid	abusers	cost	insurers	an	estimated	$72.5	billion	(Volkow	et	al,	2014)	This	financial	estimation	is	a	similar	economic	burden	as	HIV/AIDS	and	asthma.	The	projection	of	the	economic	burden	for	the	Opioid	Epidemic	unfortunately	continues	to	grow	at	a	rapid	rate.	Altarum,	a	nonprofit	health	consulting	institute	estimated	the	cost	of	the	Opioid	Epidemic	in	the	United	States	from	2001-2017	to	exceed	$1	
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trillion	(Altarum,	2018).	In	2017	alone,	the	epidemic	created	approximately	115	billion	dollars	in	waste.	
However,	the	economic	burden	does	not	dictate	the	need	for	treatment—people	still	need	help.	Where	these	victims	seek	help	and	guidance	for	treatment	of	their	addiction	varies	throughout	the	United	States,	but	as	a	consistent	rule,	Emergency	Departments	are	the	gateway	for	patients	suffering	from	substance	abuse	disorders	involving	opioids	(Hawk	and	D’Onofio,	2018).	In	consequence	of	this,	the	Emergency	Department	is	also	the	gateway	for	patients	seeking	treatment	for	opioid	abuse—where	the	furthest	interventional	advancements	occur.	Here,	clinicians	are	able	to	provide	knowledge	on	the	prescription	of	opioids,	identify	patients	potentially	suffering	from	drug	abuse,	and	reduce	patient	usage	of	opioids	through	maximization	of	alternative	medication.			
Diseases	of	Despair	Patients	in	need	of	treatment	due	to	the	opioid	epidemic	don’t	always	appear	with	a	primary	complaint	of	overdosage.	The	2017	Brookings	Report	headed	by	Case	and	Deaton	highlight	a	growing	clinical	population	within	the	United	States—patients	suffering	from	deaths	of	despair	(DoD).	Patients	suffering	from	deaths	of	despair	attribute	overdose,	completion	of	suicide,	and	death	due	to	liver	failure	directly	to	substance	abuse.	In	continuation	of	this	developed	term,	diseases	of	despair	affect	the	population	currently	suffering	from	substance	abuse	that	leads	to	these	comorbidities.	Diseases	of	despair	are	unique	in	form	due	to	the	populace	they	are	affecting.	An	article	from	the	Washington	Post	illustrates	this	unique	population	
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through	the	contrast	of	typical	populaces	suffering	from	a	chronic	disease.	Conditions	such	as	diabetes	typically	affect	minority	populations	but	statistics	show	that	DoDs	have	taken	a	stranglehold	on	middle-aged	white	people.	White	males	between	the	ages	of	45	and	55	are	the	hardest	hit	by	this	growing	affliction,	with	a	strong	correlation	between	a	lack	of	education	and	the	rate	of	the	disease.	One	article	calculated	a	four	to	six	percent	increase	in	premature	deaths	involving	DoD	in	white	people	aged	25	to	64	years	in	a	single	year	(Diez	Roux,	2017).		This	unusually	affected	demographic	bears	mentioning,	as	this	dictates	the	ability	of	physicians	to	properly	treat,	diagnose,	and	detect	opioid	abusers.	The	fact	that	white	males	are	affected	by	the	Opioid	Epidemic	more	than	any	other	population	bears	mentioning	and	monitoring	throughout	this	thesis.		Important	to	this	population	is	the	narrative	that	follows	it	towards	opioid	abuse	and	addiction.	Case	and	Deaton	stress	that	the	lack	of	education	amongst	this	population	leads	them	to	develop	these	DoDs.	With	the	current	state	of	the	economy	and	our	modern	society,	these	men	find	it	difficult	to	work	jobs	with	a	wage	to	support	a	family.	With	rates	of	diseases	of	despair	higher	in	places	of	economic	turmoil	such	as	Appalachia	and	the	Rust	Belt,	the	narrative	only	strengthens.	To	further	the	frustration	for	this	group,	their	parents	managed	to	raise	families	without	a	college	or	even	high	school	education.	So	with	this	sense	of	failure	hanging	over	their	heads,	they	become	susceptible	to	“despair”	or	a	sense	of	hopelessness.	Coupled	with	mental	illnesses,	this	leaves	these	men	vulnerable.	Ultimately,	whether	through	prescription	medication	to	combat	pain	from	an	injury	or	even	from	the	
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black	market,	they	become	exposed,	and	eventually,	addicted	to	opioids.	These	opioids	quickly	become	a	valve	with	which	they	can	ease	the	pain	of	their	DoD.		Taking	this	narrative	into	account,	the	population	of	patients	suffering	from	diseases	of	despair	remains	relatively	understudied,	undertreated,	and	underrepresented	in	previous	literature.	Evidence	clearly	shows	that	diseases	of	despair	could	develop	into	a	serious	clinical	issue.	However,	recent	evidence	believes	that	the	term	diseases	of	despair	limits	the	scope	or	even	creates	problems	in	the	proper	understanding	of	patient	populations	suffering	from	specific	ailments.	A	report	by	Bilal	and	Diez-Roux	revealed	that	the	bigger	data	shows	not	only	are	white	males	a	demographic	that	is	dying	at	an	increasing	rate—every	demographic	group	minus	non-Hispanic	white	females	are	(Bilal	and	Diez-Roux,	2019).	A	Stanford	study	supported	this	idea,	theorizing	that	the	Opioid	Epidemic	makes	a	negative	impact	on	every	demographic	throughout	the	northeastern	United	States	(Kiang	et	al.,	2019).	Woolf	and	his	colleagues	even	calculated	that	Native	Non-Hispanic	American	Indians	and	Alaskan	Natives	suffered	from	some	of	the	highest	opioid	addiction	rates	(Woolf	et	al.,	2018).		Ultimately,	diseases	of	despair	provide	compelling	perspective	and	labeling	of	a	suffering	population,	but	research	suggests	more	nuance	to	the	narrative.	One	study	highlights	that	the	Brookings	Report	missed	on	the	interaction	between	place	and	race.	These	interactions	in	turn	often	are	driven	by	other	factors	such	as	finances	and	cultural	norms	(Stein	et	al.,	2017).		The	important	points	drawn	from	these	differing	opinions	culminate	in	the	fact	that	there	are	consequences	when	framing	clinical	issues	with	specific	terms.	There	are	people	who	suffer	from	liver	
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disease,	suicidal	ideations,	and	overdose	who	don’t	fit	the	mold	of	diseases	of	despair.	Throughout	my	thesis,	I	want	to	ensure	that	I	don’t	forget	this	important	concept.	It	is	vital	to	be	sensitive	to	the	stereotyping	of	labeling	a	patient	as	someone	who	suffers	from	DoD	and	the	consequences	that	might	follow.	However,	in	terms	of	the	opioid	epidemic	I	believe	that	the	term	disease	of	despair	depicts	an	important	aspect	of	society	that	other,	more	objective	labels,	would	not.	The	emotion	of	despair	allows	the	narrative	of	the	individual	to	play	an	important	part	of	their	clinical	outcomes.	The	Opioid	Epidemic	often	dehumanizes	patients	suffering	from	addiction,	and	the	opportunity	to	include	their	narrative	in	a	clinical	diagnose	provides	a	voice	for	the	individual.		I	want	to	use	the	term	disease	of	despair	as	a	primary	target	of	a	proposed	opioid	abuse	triage	checklist,	as	the	concept	also	encapsulates	the	nuance	of	patient	presentation	in	Emergency	Departments.	A	study	conducted	in	Florida	using	the	sibling	term	“deaths	of	despair”	showed	that	such	a	targeted	field	allowed	them	to	better	categorize	their	patients,	and	ultimately	led	to	conclusive	results	(Zeglin	et	al,	2018).	Oftentimes,	patients	do	not	appear	in	the	ED	with	a	primary	complaint	of	opioid	abuse.	People	present	with	suicidal	tendencies,	liver	failure,	and	the	various	symptomology	associated	with	DoD.	However,	it	is	the	primary	cause	of	opioid	abuse	that	connects	these	patients.			
Intervention	In	order	to	direct	patients	within	the	Emergency	Department	suffering	from	opioid	abuse	towards	proper	care,	I	intend	to	conduct	an	investigation	into	the	
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potential	benefits	of	the	implementation	of	an	opioid	abuse	triage	checklist.	A	checklist,	conducted	in	real	time	by	clinicians	on	patients	that	fit	certain	criteria	(based	on	patient	history	and	current	symptomology),	would	enable	physicians	and	nurses	to	efficiently	process	the	patients.	Patient	history	will	be	an	important	factor	in	inclusion	criteria,	as	studies	suggest	it	as	a	reliable	outcome	predictor	(Barata	et	al,	2017).	This	in	turn	would	standardize	the	treatment	process,	enhance	the	physician	counseling	content,	and	optimize	referrals	to	proper	treatment	facilities	in	order	to	minimize	long-term	patient	health.	Once	processed	through	the	checklist,	this	patient’s	future	history	could	then	better	capture	the	total	symptomology	of	the	patient,	allowing	the	doctor	to	effectively	profile	and	treat	them,	as	post-treatment	history	can	be	a	powerful	clinical	tool	when	encountering	readmission	(Berg	et	al,	2018).		This	investigation	into	the	implementation	of	such	a	checklist	within	the	Emergency	Department	is	important	for	two	specific	reasons.	Primarily,	this	investigation’s	importance	rests	in	the	dire	need	of	assistance	in	the	current	Opioid	Epidemic.	As	previously	mentioned,	this	population	is	increasing	every	year,	particularly	within	Emergency	Departments.	To	develop	an	economical,	standardized	method	of	improving	patient	care	for	these	patients	would	help	mitigate	the	current	influx.	Secondly,	there	has	not	been	a	specific	interventional	study	with	this	specific	topic,	population,	and	location	in	mind.	There	have	been	investigations	(which	I	will	later	analyze	in	detail)	involving	triage	checklists	with	other	mental	illness	conditions,	and	there	has	been	profiling	of	diseases	of	despair	in	
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the	general	population,	but	these	two	components	have	not	been	synthesized	of	yet	during	my	findings.		
Pieces	of	a	Puzzle	Ultimately,	I	intend	to	begin	to	identify	the	various	pieces	of	the	puzzle	of	the	Opioid	Epidemic.	First,	it	is	important	to	provide	the	greater	context	and	space	in	which	the	opioid	epidemic	currently	is	located.	Next,	I	believe	that	focusing	in	on	a	gateway	to	healthcare,	the	Emergency	Department,	allows	for	a	concrete	lens	in	which	to	begin	understanding	the	patient	population.	An	evaluation	of	previous	interventions	within	the	Emergency	Department	on	mental	illnesses	and	multi-faceted	conditions	such	as	opioid	addiction	should	follow	this	focus.	Finally,	I	intend	to	conduct	a	brief	investigation	of	any	literature	specifically	mentioning	the	treatment,	diagnosis,	or	detection	of	opioid	addiction	within	the	Emergency	Department.	The	literature	currently	provides	extensive	material	about	the	four	separate	components	of	this	puzzle,	but	to	complete	the	greater	image	of	the	epidemic	requires	the	combination	of	these	four	concepts.		The	ultimate	intent	of	the	research	conducted	in	this	thesis	centers	around	the	ability	to	understand	the	targeted	population.	An	effective	triage	checklist	will	contain	every	element	and	characteristic	of	the	general	population	of	people	suffering	from	addiction	and	opioid	abuse.	These	characteristics	may	range	from	current	symptoms	and	conditions,	to	a	previous	record	of	prescription	opioids.	The	important	part	involves	encapsulating	all	variations	and	every	narrative	of	the	Opioid	Epidemic	without	unnecessarily	targeting	one	demographic	over	another.		
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Once	I	place	the	pieces	together,	I	intend	to	utilize	the	knowledge	gained	from	this	review	to	draft	a	comprehensive	opioid	abuse	checklist.	The	intention	of	such	a	checklist	involves	a	list	of	criterion	to	better	detect	potential	victims	of	opioid	abuse	through	components	such	as	patient	history,	history	of	diseases	of	despair,	and	a	variety	of	other	aspects	to	be	developed	in	the	continuation	of	this	thesis.	If	I	properly	synthesize	the	literature	and	glean	an	understanding	of	the	subtleties	of	this	condition,	I	believe	I	will	have	the	tools	to	develop	a	proper	triage	checklist	with	clinical	impact.			
Methods		 This	thesis	contains	five	additional	sections—a	literature	review,	an	autoethnography,	the	conclusions	made	from	this	investigation,	the	draft	of	an	opioid	abuse	triage	checklist	for	ED	use,	and	finally	a	reflection	on	future	directions	for	this	study.		As	I	previously	provided	the	initial	context	of	the	Opioid	Epidemic,	the	literature	review	aims	to	provide	a	background	on	the	specificities	of	the	condition	itself,	where	it	manifests	in	the	healthcare	mechanism,	and	how	to	best	handle	the	treatment	of	this	ailment.	More	specifically,	I	intend	to	use	the	review	to	show	each	of	the	“pieces”	that	make	up	“the	puzzle”	that	is	the	Opioid	Epidemic.	The	review	first	travels	to	the	Emergency	Department	where	it	focuses	on	the	relationship	between	this	institution	and	the	opioid	epidemic.	Then	follows	a	summation	of	the	current	treatment	protocol	involved	with	diseases	of	despair	and	opioid	use.	Finally,	I	introduce	the	concept	of	mental	health	triage	checklists	in	the	
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ED,	the	current	results	of	such	interventions,	and	the	interventions	specific	to	opioid	abuse.			 The	autoethnography	allows	me	to	provide	a	firsthand	account	of	my	time	as	a	medical	scribe	witnessing	Emergency	Department’s	interactions	with	the	opioid	epidemic	and	“diseases	of	despair”.	This	section	opens	up	the	perspective	of	not	just	patients	suffering	from	this	epidemic,	but	also	the	providers	who	struggle	to	find	the	best	practices	for	caring	for	these	people.	Here,	I	highlight	key	situations	that	shaped	the	direction	I	wanted	to	head	towards	with	my	draft	triage	checklist.		 In	my	conclusion,	I	combine	the	knowledge	learnt	from	both	experience	in	the	ED	and	data	collected	from	my	literature	review.	Here,	I	put	the	spotlight	on	specific	attributes	of	patients	suffering	from	opioid	abuse	in	the	Emergency	Department,	and	how	to	best	detect	their	presence	in	the	ED.	This	section	boils	down	the	concepts	addressed	in	the	literature	review	and	autoethnography	to	key	points	that	constitute	the	makeup	of	the	triage	checklist.	The	ultimate	goal	of	the	“diseases	of	despair”	triage	checklist	is	to	synthesize	my	understanding	of	the	patient	population	affected	by	the	Opioid	Epidemic	and	how	to	best	detect	and	diagnose	these	patients.	I	use	an	acronym	to	best	present	the	findings	in	an	easily	memorized	way.		My	intention	with	the	use	of	an	acronym	mitigates	the	amount	of	training	for	healthcare	providers.	Training,	difficult	checklists,	and	complex	processes	all	lead	to	increase	potential	in	error.	Due	to	my	lack	of	expertise	and	knowledge	in	creating	high-powered	checklists,	I	also	intended	to	keep	the	proposed	acronym	simple	and	comprehensive.			
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Literature	Review	
	
The	Emergency	Department	Patients	suffering	from	substance	abuse,	and	particularly	opioid	abuse,	find	their	easiest	access	to	care	in	Emergency	Departments.	However,	Emergency	Departments	(EDs)	are	notoriously	busy.		EDs	are	available	for	every	patient,	24/7,	and	the	consequences	of	such	an	“open	door”	policy	are	wait	times	that	can	be	measured	in	hours,	understaffing,	over-capacity,	and	a	high-stress	environment.	Recently,	there	has	been	an	incredible	uptick	in	mental	health	patients	seeking	assistance	from	Emergency	Departments.	These	patients	range	in	symptomology	from	suicidal	ideations	to	substance	abuse.	According	to	recent	studies,	approximately	one	in	eight	patients	presenting	to	the	Emergency	Department	has	mental	health	as	a	primary	complaint	(Pearlmutter	et	al,	2017).	If	we	apply	that	statistic	to	the	141.4	million	people	that	visit	the	Emergency	Department	annually,	we	are	now	studying	a	demographic	17.68	million	large.	This	is	by	no	means	an	insignificant	population.		Unfortunately,	Emergency	Department	does	not	have	the	resources	to	properly	treat	a	situation	as	delicate	and	complex	as	a	patient	with	a	mental	illness	(Pearlmutter	et	al,	2017).	ED	physicians	and	nurses	are	highly	specialized	staff,	but	do	not	necessarily	have	the	requisite	training	for	a	patient	in	need	of	more	long-term	attendance	rather	than	short-term	stabilization.	ED	staff	train	and	practice	an	effective	method	of	stabilizing	patients	and	either	admitting	them	for	further	intensive	care,	or	sending	them	back	with	instructions	on	follow-up	care.	This	
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allows	patients	to	receive	immediate	care	in	the	ED,	but	their	purpose	simply	does	not	lie	in	extended	care.	Patients	suffering	from	mental	illnesses,	particularly	those	with	addiction,	require	a	more	invested	approach.	Typically,	these	patients	present	consistently	either	with	untreated	health	issues,	or	with	a	phantom	illness	manifested	through	the	patient’s	mental	health	troubles.	As	their	mental	illnesses	go	untreated,	due	to	either	the	primary	issue	being	another	health	problem	or	the	ED’s	inability	to	effectively	treat	mental	illnesses,	they	continue	to	return	to	the	Emergency	Department	over	and	over	again.	This	leads	to	a	distasteful,	but	accurate	term	known	as	“frequent	flyers”—patients	who	show	up	to	the	ED	daily	or	sometimes	more.		Although	current	protocol	for	substance	abuse	involves	both	counseling	and	medically	assisted	treatment,	the	initial	issue	rests	in	the	over-prescription	of	opioids.	Doctors	for	a	time	over-prescribed	these	medications	as	pain	panaceas.	Due	to	the	rise	of	the	Opioid	Epidemic,	implemented	standards	now	mandate	an	increased	difficulty	for	prescribing	opioids.	These	standards	include	training	in	opioid	prescription.	A	population	of	physicians	however,	would	rather	not	play	with	fire	at	all—a	study	conducted	by	Nelson	and	Perrone	in	2012	showed	that	13.4%	of	259	physicians	reported	they	would	no	longer	prescribe	an	opioid	if	they	were	required	to	obtain	4	to	8	hours	of	training	and	2	hours	of	continuing	medical	education	every	2	years	in	order	to	be	licensed	to	prescribe.	This	provides	hope	that	the	prescribing	of	opioids	will	decrease,	but	not	at	rates	that	remove	the	need	to	increase	access	to	proper	therapy.	The	importance	rests	in	finding	a	mechanism	that	minimizes	additional	work,	but	maximizes	directed	care.		
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Patients	who	suffer	from	substance	abuse	tend	to	be	the	most	difficult	cases	to	properly	assess	and	treat	in	EDs.	In	“Trends	in	Emergency	Department	Visits,	2006-2014”	the	situation	is	summated	to	the	equivalent	of	a	“widespread	problem”	throughout	the	nation,	regardless	of	location.	These	patients	sometimes	present	with	secondary	outcomes	such	as	needle-stick	infections.	These	comorbidities	can	effectively	be	linked	to	a	primary	outcome	of	an	opioid	addiction,	preemptively	locating	patients	of	substance	abuse	(Miller	and	Polgreen,	2018).		In	order	to	best	compensate	for	this	rising	demographic,	Emergency	Department	researchers	have	spent	extensive	time	creating	and	implementing	various	organizational	strategies	to	increase	efficiency	and	workflow.	In	fact,	an	entire	academic	landscape	surrounding	the	implementation	of	organizational	frameworks	exists.	Each	framework	has	its	own	unique	goal	designed	to	increase	or	reduce	various	qualities	and	characteristics	of	the	Emergency	Department.	However,	according	to	Pearlmutter,	wait	times	before	disposition	are	the	best	predictor	of	health	outcomes	for	mentally	ill	patients,	and	the	Emergency	Department	as	a	whole.	If	these	clinics	are	able	to	reduce	the	wait	time	for	mentally	ill	patients	to	be	medically	cleared	for	transport	to	a	mental	health	facility,	such	as	a	psychiatric	hospital,	the	overall	health	outcomes	of	the	patients	themselves	dramatically	increases.	Furthermore,	the	decrease	in	time	until	disposition	allows	for	a	larger	number	of	patients	to	flow	through	the	Department	itself,	as	beds	free	up	faster.		
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Standard	of	Care	As	previously	introduced,	the	Opioid	Epidemic	requires	an	in-depth	understanding	of	the	current	standard	of	care	for	combating	opioid	addiction,	which	involves	a	combination	of	counseling	and	medication	(Volkow	et	al,	2014).	In	particular,	there	are	three	specific	medications	that	create	the	profile	of	addiction-fighting	drugs—methadone,	buprenorphine,	and	naltrexone.	Each	medication	has	a	specific	purpose	when	fighting	addiction.		Methadone	is	an	opioid	agonist,	meaning	it	targets	the	same	receptors	as	opioids.	This	mechanism	provides	an	advantage	by	mitigating	opioid	cravings	through	the	oral	intake	of	methadone.	The	drug	has	few	pharmacological	flaws,	but	unfortunately	is	difficult	to	access	(Volkow	et	al,	2014).	Methadone	outpatient	clinics	must	be	visited	daily	to	receive	a	dosage,	which	in	turn	inconveniences	consistent	therapy.		Buprenorphine	is	a	partial	agonist,	which	targets	the	same	receptor,	but	the	patient	then	receives	a	diminished	response	from	activation	of	the	receptor	with	buprenorphine,	rather	than	a	full	response	as	with	methadone.	Buprenorphine	can	be	prescribed	by	physicians,	eliminating	the	difficulty	of	daily	clinic	visits;	however,	it	is	not	as	effective	in	diminishing	craving	and	withdrawal	symptoms.	One	noticeable	danger	in	the	administration	of	buprenorphine	is	that	brand	names	such	as	Subutex	carry	a	degree	of	abuse	liability,	although	another	known	brand	name,	Suboxone,	counters	this	by	including	naloxone—an	antagonist	that	immediately	induces	withdrawal	if	injected	directly	(Wilkerson	et	al,	2016).	This	ensures	that	patients	cannot	intravenously	consume	large	quantities	of	the	partial	agonist.		
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The	final	standard	of	care	drug,	known	as	naltrexone,	is	an	antagonist,	signifying	that	the	medication	interferes	with	the	reward	and	analgesic	properties	of	the	opioid	receptors	when	blocking	them.	This	allows	patients	to	intravenously	or	orally	ingest	the	drug	in	order	to	break	the	conditioned	stimulus	of	opioid	abuse.	As	the	pleasure	stimulus	is	rendered	ineffective,	eventually	the	patient	will	be	able	to	disassociate	the	desire	for	release	or	reward	with	opioids.	A	study	even	showed	that	when	naloxone	was	provided	to	patients	suffering	from	overdose	via	EMS,	their	outcomes	within	the	ED	increased	dramatically	(Dworkis,	Weiner,	Liao,	Rabickow,	and	Goldber,	2018).		Vivitrol,	one	of	the	newest	brand	names	of	this	drug	family,	can	even	be	taken	as	a	single	use	depot	shot,	allowing	an	easy	administration	of	the	antagonist.	The	stimulus	may	be	effectively	rendered	inert	from	the	usage	of	opioids,	but	patients	will	still	unfortunately	experience	withdrawal	symptoms	and	potential	relapse	during	this	period.	Thus,	this	family	of	medication	often	has	low	patient	compliance	(Volkow	et	al,	2014).	Investigations	into	these	medications	from	a	molecular	level	have	demonstrated	that	mechanistically,	these	families	of	drugs	remain	the	future	and	gold	standard	of	therapy	(Liu	et	al,	2018).		
Triage	Checklists	The	faster	a	clinic	can	transfer	their	rising	and	significant	mental	health	population	to	the	proper	centers	they	need	to	be	in,	the	more	time	they	will	consequently	have	for	other	patients.	An	example	of	a	method	utilized	to	decrease	wait	times	for	mental	health	patients	is	a	mental	health	triage	system.	Before	a	patient	even	sees	a	hospital	bed,	the	triage	nurses	and	physicians	are	trained	to	
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effectively	assess	and	diagnose	the	severity	of	a	patient’s	condition	in	comparison	to	others.	However,	the	triage	checklist	focuses	on	more	physiological	ailments	and	is	limited	in	its	analysis	of	mental	health	patients.	The	creation	of	a	unit-specific	mental	health	triage	checklist	allows	these	patients	to	be	effectively	categorized,	cleared	as	medically	healthy,	and	prepared	for	discharge	and	disposition	faster	(Broadbent,	Jarman,	and	Berk,	2002).	Broadbent,	one	of	the	leading	researchers	in	mental	health	triage,	has	implemented	various	studies	in	Australian	Emergency	Clinics,	with	statistically	significant	results.	Of	note,	the	particular	triage	mechanism	used	by	Broadbent	provided	a	clinical	diagnoses	needing	immediate	medical	transfer	to	an	intensive	care	psychiatric	facility.	It	proved	effective,	and	future	studies	included	widening	the	expanse	and	inclusive	symptomology	of	the	checklist	itself	(Broadbent,	Jarman,	and	Berk,	2004).		A	study	conducted	by	McDonough,	Wynaden,	Finn,	McGowan,	Chapman,	and	Hood	in	2004	further	supports	the	predicted	impact	of	mental	health	triage	implementation.	This	particular	investigation	noted	the	reverberations	of	such	implementation	throughout	the	hospital.	The	team	reported	decreased	wait	times	overall,	increased	reported	quality	of	care	by	all	patients,	and	a	decrease	in	negative	clinical	health	outcomes	as	a	direct	consequence	of	increased	average	physician	time	per	patient.	Another	research	group	conducting	triage	investigations	noted	that	a	key	component	of	the	mental	health	triage	system	was	that	it	did	not	specifically	isolate	a	population.	Rather	it	provided	a	different	“lane”	for	the	patients	to	travel	on	the	highway	that	is	an	Emergency	Department.	The	flow	of	traffic	then	is	allowed	to	be	separate,	while	the	patients	themselves	are	not	sequestered	into	their	
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own	area—minimizing	stigmatization	or	isolation	for	this	vulnerable	population	(Smart,	Pollard,	and	Walpole,	1999).	When	understanding	the	situation	for	patients	suffering	from	a	mental	illness,	the	impact	of	time	spent	in	the	ED	for	a	patient	suffering	from	addiction	is	clear.	The	need	to	refer	patients	from	the	ED	is	apparent,	and	needs	to	be	a	priority	of	any	checklist	developed	to	serve	this	population.	
	
Opioid	Interventions		 Access	to	medications	remains	an	issue,	which	largely	renders	their	potency	and	ability	to	combat	the	physiological	symptoms	of	addiction	ineffective.	The	National	Survey	on	Drug	Abuse	and	Health	states	that	of	the	2.5	million	Americans	who	abused	prescription	opioids	in	2012,	less	than	1	million	of	these	patients	had	access	to	medication-assisted	therapy.	Volkow	and	her	team	attribute	this	limited	access	to	a	few	specific	factors.	First,	there	is	a	dearth	of	trained	prescribers	of	both	opioids	and	addiction-breaking	drugs,	which	prevents	patients	who	seek	help	from	effectively	being	referred	to	the	proper	care.	In	addition,	the	public	perception	of	institutions	such	as	methadone	clinics	and	the	medications	themselves	are	widely	negative	due	to	a	misunderstanding	of	how	the	drugs	biochemically	assist	in	breaking	addiction.	To	further	decrease	accessibility	to	proper	treatment,	few	private	insurance	plans	cover	naltrexone,	and	most	do	not	cover	methadone	(Volkow	et	al,	2014).	The	added	financial	burden	combined	with	social	perception	and	a	lack	of	trained	administrators	explains	why	patients	suffering	from	opioid	addiction	are	so	far	away	from	effective	medication.	
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As	can	be	seen,	the	world	of	the	Opioid	Epidemic	is	nuanced;	the	future	of	treatments	and	fighting	this	epidemic,	more	so.	The	interventions	presented	will	involve	patients	suffering	from	DoD	who	have	received	some	form	of	interventional	treatment	from	2016	to	the	present.	This	was	instituted	in	order	to	investigate	the	current	standards	of	care,	even	if	this	might	narrow	the	frame	away	from	all	possible	care	methods.		In	2016,	physician	Dr.	Vivek	Murthy	sent	a	pocket	card	to	approximately	2.3	million	clinicians	with	a	plea	to	work	together	to	end	the	rising	health	crisis	of	opioid	addiction.	The	pocket	card	functions	as	an	effective	checklist	for	prescribers	of	opioids	to	use	in	order	to	prevent	mismanagement	of	these	addictive	drugs.	The	checklist	allows	the	prescriber	to	ask	self-evaluating	questions	on	the	current	situation	involved	with	the	patient.	It	assesses	if	there	are	alternatives,	suggests	the	usage	of	quick-release	low	dosage	opioids,	and	forces	the	clinicians	at	the	very	least	to	pause	and	consider	the	consequences	of	prescribing	opioid	pain	analgesics	(Murthy,	2016).		Murthy	now	holds	the	position	of	Surgeon	General	of	the	United	States,	and	continues	to	press	for	further	awareness	of	the	dangers	of	prescription	opioids.		Another	study	also	supports	this	path,	particularly	with	the	use	of	fast-release	opioids	to	combat	potential	addiction	(Sproule	et	al,	2009).	There	are	no	reports	on	the	efficacy	of	the	card	in	terms	of	health	outcomes,	but	there	is	content	that	warrants	evaluation.	The	validity	of	the	pocket	card	and	checklist	is	supported	by	the	validity	of	the	main	influencers	of	the	checklist.	In	short,	a	trained	physician	knowledgeable	on	opioids	created	this	checklist	with	influences	and	data	from	the	
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CDC	and	SAMHSA	with	intent	for	fellow	administrators	to	use.	The	checklist	carries	a	degree	of	reliability,	as	it	is	a	highly	regulated	checklist	with	a	step-by-step	process,	which	supports	consistency	in	treatment	and	administration.	The	intuitive	formulation	of	the	checklist	also	suggests	a	degree	of	simplicity	and	potential	compliance.	The	focus	on	personal,	but	standardized	use	of	the	pocket	card	in	a	variety	of	healthcare	settings	allows	administrators	to	be	flexible	in	their	methodology.		Due	to	this	being	a	simple	pocket	card	of	paper,	there	is	limited	cost	to	the	overall	intervention.	This	is	a	major	benefit	of	the	study,	and	in	fact	the	implementation	of	this	method	could	save	money	considering	the	overall	cost	of	opioid	abuse,	the	potential	to	reduce	addiction	rates,	and	the	guaranteed	reduction	of	overall	opioid	prescriptions	in	clinical	settings.	A	note	of	concern	in	all	interventions	in	this	field	is	that	it	is	important	that	patients	still	receive	necessary	pain	relief.	This	study	practices	this	by	the	utilization	of	alternative	pain	therapies.	Furthermore,	a	reduction	rather	than	elimination	of	prescriptions	is	important,	as	opioids	are	still	the	gold	standard	in	specific	cases	of	pain	management.	If	this	pocket	card	continues	to	be	used	in	a	standardized	way	by	clinicians	and	taught	to	trainees	in	the	field,	sustainability	for	this	intervention	can	remain	high,	and	in	fact	this	intervention	could	become	the	standard	of	care	for	prescribing	opioids.		A	potential	issue	that	may	appear	in	the	future	when	analyzing	the	results	of	this	study	is	that	the	results	of	proper	intervention	are	long-term	health	outcomes,	which	are	difficult	to	capture	with	high	fidelity	due	to	a	primary	need	of	compliance	from	a	historically	noncompliant	and	unreliable	population	over	a	period	of	time.	In	
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order	to	combat	this	issue,	it	would	require	a	two-step	approach,	as	most	clients	would	be	seen	in	the	ED,	where	checkups	are	not	the	standard	protocol.	There	would	need	to	be	a	strong	referral	system	in	place	with	accessible	primary	care	physicians	who	could	check	up	on	clinical	outcomes	after	specific	periods	of	time.	There	are	few	controversies	involved	in	this	study,	but	the	drastic	change	in	opioid	prescriptions	and	the	potential	of	ineffectively	treating	certain	pain	could	lead	to	issues.	Another	point	of	contention	is	the	fact	that	the	current	population	suffering	from	DoD	receives	no	novel	treatment	as	consequence	of	the	intervention,	but	rather	the	study	focuses	on	mitigating	the	growth	rate	and	development	of	any	future	populations.	The	National	Drug	Abuse	Clinical	Trials	Network	sponsored	a	Prescription	Opioid	Addiction	Treatment	Study	(POATS)	with	the	aim	of	further	understanding	pharmacologic	and	psychosocial	therapies	for	opioid	addicts.	This	particular	study	utilized	buprenorphine	as	the	pharmacotherapy,	with	individual	opioid	drug	counseling	serving	as	the	psychotherapy	(Weiss	and	Rao,	2017).	There	were	two	legs	of	the	study,	with	one	being	the	primary	four	week	intervention	with	two	weeks	of	buprenorphine	taper	and	eight	weeks	of	assessment	follow	ups.	The	other	leg	consisted	of	an	optional	twelve-week	study	with	a	similar	taper	and	follow	up.	The	aim	was	for	two	separate	groups,	one	who	underwent	purely	pharmacotherapy	and	other	who	were	given	a	mixed	methods	approach,	to	follow	through	the	first	study.	If	they	were	unsuccessful	in	breaking	their	addiction,	they	were	offered	an	option	to	participate	in	the	twelve-week	intervention.		
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The	overall	results	were	mixed	at	best,	with	the	12-week	leg	of	the	trial	only	demonstrating	49%	success,	and	the	4-week	rendering	a	less	than	7%	success	rate	without	relapse.	This	is	the	first	large	scale	interventional	treatment	study	of	opioid	addiction	of	its	kind,	but	the	methodology	of	treatment	allowed	for	a	high	level	of	validity.	As	there	were	two	levels	of	treatment	throughout	the	study,	patients	were	monitored	over	the	course	of	a	long	time.	This	combined	with	extensive	opioid	urine	tests	allowed	for	certainty	in	results	in	terms	of	breaking	the	addiction	of	the	patients.	The	high	sample	size	of	653	patients	provides	a	large	enough	group	for	reliable	analysis,	as	the	results	were	statistically	significant	with	significant	statistical	power	as	well.	This	study	required	the	use	of	a	wide	number	of	administrators	due	to	the	relatively	large	sample	size	and	the	high	level	of	intervention	(clinicians	for	drug	administration,	counseling,	follow	ups,	opioid	testing,	etc.).	The	cost	of	this	study	was	undoubtedly	high,	due	to	the	large	national	scale	it	occurred	on,	the	nature	of	the	study,	and	the	cost	of	personnel,	equipment,	and	treatment.	The	justification	for	cost	lays	in	the	high	fidelity	of	results	drawn	from	the	investigation.	The	overall	goal	of	the	study	was	to	help	willing	subjects	break	their	opioid	addiction	through	the	use	of	humane	pharmacotherapy	and	supplemental	drug	counseling	for	the	second	subject	group.		The	current	standard	of	care	for	all	subjects	was	implemented	with	the	intent	of	helping	all	subjects	break	addiction	to	opioids.	This	was	further	attempted	through	the	use	of	the	second,	longer-lasting	study	for	those	who	failed	the	initial.	Overall,	this	was	a	high	standard	treatment	and	only	served	to	benefit	those	who	maintained	the	course	of	the	trial.	This	study	was	a	high-strain,	high-cost,	long-term	
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investigation,	which	in	turn	is	not	sustainable.	However,	the	evidence	gleaned	from	the	methodology	has	sustaining	power	within	the	community,	as	the	results	are	valid	and	reliable.	The	new	standard	of	care	that	could	be	influenced	by	the	results	of	this	study	would	thusly	have	a	high	sustainability.	Although	the	outcomes	being	analyzed	were	easily	and	reliably	measured,	the	results	of	the	study	were	not	overwhelmingly	leaned	towards	a	positive	or	negative	conclusion.	This	insecurity	of	results	could	lead	to	analytic	issues	and	prevent	results	from	reaching	maximum	statistical	strength.	Treatment	fidelity	has	already	begun	to	be	ensured	by	a	series	of	follow	up	tests,	one	notably	being	conducted	at	the	University	of	Vermont	with	the	intent	of	replicating	the	study	and	further	modifying	trial	periods	to	maximize	results	(Weiss	and	Rao,	2017).	There	were	minimal	controversies	associated	with	subjects	undergoing	the	studies.	However,	the	results	themselves	are	controversial	in	that	they	show	that	the	current	standard	of	care	for	treating	opioid	addiction,	including	the	supplement	of	drug	counseling,	is	widely	ineffective.	This	combined	with	the	statistics	of	access	to	pharmacotherapy	leads	to	a	bleak	outlook	on	the	current	opioid	epidemic	treatment.	At	this	point	in	time	in	research	in	this	field,	larger	focusing-studies	provide	the	ability	to	understand	opioid	addiction	and	the	variety	of	therapy	inside	the	Emergency	Department.	A	meta-analysis	of	these	studies	conglomerated	the	conclusions	into	a	clear	picture	of	the	future	of	treatment	for	DoD	in	the	ED	(Hawk	and	D’onofrio,	2018).	The	intent	is	to	utilize	buprenorphine,	refer	patients	to	long-term	care,	and	conduct	rapid	counseling	and	therapy	before	patient	disposition.	Studies	found	equivalent	results	of	reduction	in	illicit	drug	use	after	intervention.	In	
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particular,	the	use	of	medication	assisted	therapy	with	brief	counseling	and	direct	referral	had	the	largest	effect	on	long-term	outcomes.	The	validity	and	reliability	of	this	claim	can	be	solidified	with	the	sheer	amount	of	evidence	provided	by	the	meta-analysis—over	four	randomized	clinical	trials	(RCTs)	mentioned	came	to	similar	conclusions	on	ideal	therapy.	The	various	RCT’s	had	a	variety	of	financial	burdens,	with	the	most	expensive	trials	focusing	on	medication.	However,	the	meta-analysis	simply	required	the	cost	of	a	statistical	study.		There	was	no	human	intervention	in	this	overview,	but	all	of	the	studies	used	for	analysis	demonstrated	high	levels	of	fidelity	with	the	baseline	already	the	standard	of	care	and	improvements	upon	this	being	the	various	legs	of	studies	(medication	and	therapy,	intense	referral	systems,	etc.).	The	amount	of	evidence	was	overwhelmingly	in	favor	of	interventional	methodology	in	Emergency	Departments,	suggesting	a	clinical	need	for	sustaining	these	practices.	The	only	issues	that	may	have	occurred	in	analysis	involved	the	lack	of	a	standardized	statistical	evaluation	of	each	method,	as	this	was	simply	a	review	of	the	results	of	RCTs.	A	potential	usage	of	a	unifying	statistic	measuring	outcomes	would	have	dramatically	increased	the	power	of	the	results	of	this	study.	Through	this	study,	one	can	utilize	the	various	interventions	as	influences	on	a	future	treatment	protocol.	The	only	controversies	involved	the	varying	study	types	and	the	lack	of	a	unifying	analysis.		 When	assessing	the	current	state	of	the	healthcare	industry’s	fight	against	the	Opioid	Epidemic,	these	three	examples	of	interventional	studies	show	how	promising	the	future	is.	However,	there	is	still	work	to	be	done.	Within	the	social	sphere,	there	is	a	desperate	need	to	reduce	the	stigma	surrounding	anti-addiction	
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medications,	and	the	culture	of	prescribing	opioids	needs	to	change.	Even	with	promising	medication-assisted	therapies,	the	results	are	not	quite	where	they	need	to	be	in	terms	of	medication	efficacy.	This	can	be	attributed	to	social,	pharmacological,	and	clinical	factors	that	various	articles	have	pointed	out.	The	POATS	study	ultimately	has	shown	that	the	nuanced	task	of	treating	patients	involves	both	counseling	and	medication.	Dr.	Murthy	mentions	how	government	funding	could	go	milestones	towards	providing	adequate	educational	resources	for	clinicians	who	prescribe	pain	medications.	This	on	its	own	puts	a	stem	on	the	flood	of	future	victims	of	opioid	addiction.	Quality	improvement	is	a	constant	process	that	has	been	helped	with	the	investigations	of	Emergency	Department	opioid	addiction	treatment	protocol	as	well	as	effective	long-term	treatments	for	long-term	health	outcomes.	As	the	scientific	community	continues	to	concrete	the	foundations	and	paint	in	the	nuances	of	the	entire	picture	of	the	Opioid	Epidemic,	the	daunting	issues	faced	become	clearer	and	more	objective.	The	results	suggest	that	with	extra	attention	from	policy	makers	and	government	funding,	leaps	and	bounds	can	be	made	in	preventing	and	curing	opioid	addiction—saving	thousands	and	counting.		
Autoethnography	As	I	scribed	in	the	St.	Thomas	Midtown	Emergency	Department	(ED),	I	witnessed	the	impact	of	Emergency	Medical	Services	on	the	local	population.	Specifically,	I	observed	how	physicians,	nurses,	and	technicians	helped	treat	patients	suffering	from	mental	illnesses	and	substance	abuse.	Throughout	my	undergraduate	and	graduate	studies,	I	read	extensively	on	the	ED	being	a	“gateway”	
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for	these	disenfranchised	victims	of	addiction	and	mental	ailments,	but	seeing	events	happen	in	real	life	provided	an	unequivocal	experience.	A	statistic	mentioned	in	this	paper	cites	that	approximately	one	in	eight	patients	arrive	at	the	Emergency	Department	with	a	mental	health	issue.	Scribing	for	physicians	during	night	shifts	and	weekend	shifts,	I	now	believe	that	statistic	to	be	much	higher.	Even	if	a	patient	presented	to	the	ED	with	a	primary	issue	of	an	injury	or	physical	ailment,	oftentimes	it	was	clear	that	numerous	people	needed	psychiatric	assistance	as	well.		What	I	did	not	expect	to	find	in	my	time	as	a	scribe	were	jaded	healthcare	providers.	The	mentality	of	ED	nurses	and	physicians	during	my	time	working	was	best	summed	up	by	one	of	the	nurses	as	a	psychiatric	patient	returned	for	the	second	time	in	the	same	day	“Here	they	come	again.”	I	think	on	this	phrase,	and	my	first	instinct	leads	me	to	believe	such	statements	are	problematic,	heartless,	and	cold.	However,	I	also	understood	the	frustration,	hopelessness,	and	resentment	the	nurses	and	physicians	felt.	How	could	I	expect	a	nurse	to	do	vitals	on	the	same	person	6	times	in	a	week	even	if	there	were	no	physical	impairments	on	the	patient?	How	would	I	feel	if	a	woman	hurled	abuse	and	literal	refuse	at	me	whenever	I	walked	into	the	room?	Would	I	treat	that	patient	with	a	smile?	The	world	of	the	Emergency	Department	and	the	relationship	between	the	ED	and	its	mental	health	patients	remains	complicated,	and	unless	a	drastic	shift	in	the	treatment	of	those	with	substance	abuse	and/or	mental	illnesses	changes,	change	won’t	happen.	According	to	the	literature,	the	Emergency	Department	specializes	in	stabilizing	patients	in	order	for	them	to	transition	to	their	best	method	of	care.	According	to	my	firsthand	experience,	this	remains	undoubtedly	fact.	However,	the	caveat	involves	
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this	specific	demographic.	An	ineffective	system	of	patient	referral	lets	patients	with	an	opioid	addiction	or	other	mental	illness	leave	the	Emergency	Department	with	no	guarantee	of	their	visit	to	proper	healthcare	providers.	Overcrowding,	overworking,	and	the	desensitization	of	providers	to	mentally	ill	patients	and	addicted	patients	remove	empathy	from	the	ED.		When	specifically	monitoring	the	state	of	patients	suffering	from	opioid	addiction,	I	learned	that	their	true	state	of	dependence	often	hides	behind	a	veil.	I	recall	one	patient	presenting	with	a	severe	light-sensitive	migraine.	He	told	the	physician	that	he	often	got	these	migraines	and	that	“I	just	need	Lortab,	I	know	that	helps	with	the	pain.”	Lortab	is	one	of	the	largest	opioids	on	the	market,	and	the	physician	immediately	told	him	they	would	not	be	providing	any	form	of	opioid	to	him	today	as	part	of	his	pain	management.	He	refused	any	other	pain	alternatives.	Within	two	to	three	minutes	of	the	physician	and	I	walking	out,	the	patient	got	up	and	walked	out	of	the	Emergency	Department	with	no	desire	for	further	treatment.		To	my	untrained	eye,	he	seemed	like	a	patient	with	a	dire	need	of	pain	relief.	To	my	physician,	he	was	just	another	victim	of	addiction	looking	for	his	fix.	When	we	looked	back	at	his	patient	record,	sure	enough	he	had	a	long	history	of	opioid	use	for	various	pain	complaints.	This	experience	completely	changed	my	perspective	on	the	stereotype	of	a	patient	suffering	from	diseases	of	despair	and	addiction	within	the	ED.	There	remained	a	whole	subgroup	of	patients	that	I	never	thought	to	include	in	my	ongoing	triage	checklist—those	with	a	different	physical	presentation,	but	an	underlying	desire	to	receive	opioids	from	the	ED	itself.		
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In	summary,	the	most	important	word	to	associate	with	my	experiences	as	a	medical	scribe	is	perspective.	The	perspective	of	the	incredibly	determined	and	hardworking	nurses	and	physicians	of	Emergency	Departments	opened	me	to	a	struggle	many	providers	feel	they	have	already	lost.	The	opioid	epidemic	and	the	lack	of	proper	mental	healthcare	pathways	outside	of	the	Emergency	Departments	flood	the	waiting	rooms	and	department	beds	with	patients	better	treated	outside	the	ED.	With	the	implementation	of	a	targeted	protocol	such	as	a	triage	checklist,	these	providers	can	quickly	diagnose,	assess,	and	refer	patients.	This	eliminates	the	tediousness	of	re-diagnosing	a	patient	every	visit	to	the	ED	and	better	finds	the	patients	hiding	their	addictions	behind	other	ailments.	If	the	cumulative	impact	results	in	a	decreased	disposition	time	for	patients	suffering	from	diseases	of	despair,	the	providers	themselves	can	feel	the	reverberation	of	such	a	consequence.	I	believe	that	less	time	practicing	inefficient	care,	more	time	designated	to	more	patients,	and	the	thought	that	their	work	is	increasing	health	outcomes	for	patients	previously	thought	“hopeless	causes”	could	bring	empathy	back	into	the	ED.		
Conclusions	When	placing	the	piece	of	the	puzzle	together,	the	full	picture	comes	to	light.	The	Opioid	Epidemic	is	here	to	stay	in	the	United	States,	and	the	struggle	to	treat	patients	of	this	Epidemic	will	continue	unless	deliberate	measures	are	taken.	As	this	story	unfolds,	the	victims	of	addiction	stand	apparent.	The	National	Institute	on	Drug	Abuse	reports	that	one	in	four	patients	prescribed	an	opioid	for	pain	management	became	addicted.	The	NDI	also	reports	that	in	2017,	the	mortality	rate	
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rose	to	47,800	deaths.	Ineffective	medications,	disorganized	healthcare	units,	and	a	lack	of	consensus	render	our	ultimate	struggle	against	this	drug	thus	far	inadequate	(Nelson	et	al,	2015).	To	further	the	direness	of	the	situation,	evidence	demonstrates	that	abusing	opioids	increases	one’s	chance	of	diverting	to	unstable	and	unregulated	drugs	such	as	heroin	and	fentanyl	(Dasgupta	et	al,	2017).	When	each	of	these	components	are	placed	next	to	each	other	it	depicts	a	concerning	image—a	population	that	remains	susceptible	to	addiction,	grows	in	size	every	year,	and	exposes	itself	to	further	dangers.	The	main	venue	catering	to	patients	suffering	from	addiction,	Emergency	Departments	provide	an	opening	in	which	researchers	can	make	an	impact.	One	in	eight	patients	presenting	to	the	Emergency	Department	presented	with	a	primary	complaint	of	mental	health	issues	(Pearlmutter	et	al,	2017).	Within	this	population	of	17.68	million,	a	substantial	portion	of	patients	come	in	contact	with,	or	develop	an	addiction	to	opioids.	Although	Emergency	Departments	currently	do	not	contain	the	essential	arsenal	to	combat	opioid	overdosage,	addiction,	and	abuse,	the	ability	to	implement	interventions	within	this	sector	open	up	opportunities	to	treat	these	condition.	A	metric	or	unit	of	measurement	is	important	order	to	best	quantify	and	analyze	the	efficacy	of	an	intervention.	Pearlmutter	and	his	associates,	a	team	of	scientists	dedicated	to	better	treating	mental	illnesses	within	Emergency	Departments,	came	to	the	consensus	that	wait	time	until	disposition	is	the	most	effective	unit	of	measurement	in	predicting	improved	health	outcomes.	Although	generalizable	to	most	ailments	seen	in	the	Emergency	Department,	decreasing	the	
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time	until	disposition	drastically	improves	health	outcomes	for	opioid	addiction	and	diseases	of	despair,	because	the	faster	a	patient	transitions	to	long-term	and	more	appropriate	care,	the	faster	their	opportunity	to	improve	their	condition.	The	reasoning	involves	the	current	standard	of	treatment	for	patients	suffering	from	diseases	of	despair.	These	ailments	are	best	treated	in	facilities	outside	of	the	Emergency	Department.	Thusly,	the	quicker	a	physician	can	refer	a	patient	and	schedule	essential	visits	with	proper	personnel,	the	further	in-control	the	situation	gets.		An	effective	method	of	reducing	time	until	disposition	involves	faster	detection	and	diagnosis.	In	order	to	limit	the	extra	processes	involved	in	doing	so,	a	triage	checklist	provides	an	efficient	mechanism	that	fits	seamlessly	into	the	workflow	of	physicians,	nurses,	and	technicians	within	the	Emergency	Department.	For	such	a	targeted	checklist,	patient	history	would	be	effectively	recorded	as	part	of	the	workflow.	Studies	show	that	well	recorded	and	thorough	notation	of	patient	history	develops	into	a	reliable	outcome	predictor	as	the	starting	point	for	any	readmission	steadily	pushes	further	into	treatment	itself	(Barata	et	al,	2017).	Essentially,	every	time	a	patient	returns	to	the	ED,	the	physicians	can	look	at	their	history,	and	start	further	ahead	than	if	they	did	not	have	access	to	a	detailed	patient	story.	In	turn	the	history	speeds	up	physical	evaluations,	enhances	physician	counseling,	and	maximizes	referral	resources.					
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Putting	the	Puzzle	Together	The	culmination	of	the	accumulation	of	this	information	involves	the	physical	manifestation	of	a	triage	checklist	for	the	Emergency	Department	focused	on	detecting	and	diagnosing	patients	suffering	from	opioid-centric	diseases	of	despair.	An	effective	checklist	will	contain	the	main	“pieces	of	the	puzzle”	that	has	been	put	together	using	the	literature	review	and	autoethnography.	In	other	words,	there	are	certain	characteristics	previously	emphasized	that	effectively	summarize	the	patient	population	of	opioid	addicts	interacting	with	the	Emergency	Department.	An	important	component	of	the	triage	checklist	provides	protection	against	patients	presenting	as	an	alternative	ailment	such	as	diseases	of	despair.	For	example,	numerous	patients	present	with	a	primary	complaint	of	suicidal	tendencies,	liver	failure,	and	substance	overdose.	These	patients	could	slip	through	the	cracks	of	a	checklist	if	not	properly	assessed	on	these	second	level	of	characteristics	(comorbidities	to	opioid	addiction).	Another	population	that	can	bypass	the	initial	screen	is	patients	seeking	opioids	within	the	Emergency	Department	for	their	“pain.”	Opioid	addicts	may	present	for	a	phantom	injury	or	pain	to	access	their	needed	drug.	This	can	often	be	detected	due	to	the	inability	of	the	patient	to	create	a	cohesive	patient	history	or	their	demand	for	a	specific	medication	to	cure	their	ailments,	like	in	the	case	of	the	patient	who	“just	needed	Lortab”	for	his	migraine.		A	key	population	often	missed	is	patients	who	develop	secondary	consequences	of	drug	abuse,	such	as	wounds	and	withdrawal	symptoms.	An	example	of	an	infection	patient	who	suffers	from	opioid	abuse	would	be	an	individual	with	MRSA	
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infected	needle-stick	wounds	due	to	injection	of	opioids	with	tainted	needles—not	an	uncommon	occurrence	in	the	Emergency	Department.	However,	due	to	the	urgency	of	a	MRSA	infection,	attention	is	diverted	from	the	long-term	opioid	addiction	and	towards	the	immediate	issue.	With	a	quick	and	efficient	triage	of	the	patient’s	relationship	with	opioid	addiction	using	the	checklist,	the	patient	could	then	seek	long-term	care	for	their	addiction	after	their	immediate	curing	of	their	infection.	The	essential	core	of	a	triage	checklist	such	as	this	one	involves	understanding	the	patient	population,	the	subtleties	of	the	primary	condition,	and	how	to	approach	the	relationship	between	these	two	concepts.	The	patient	population	is	complex,	not	easily	spotted,	and	often	unmotivated	to	change	habits.	Through	a	synthesis	of	the	literature,	however,	there	are	trends	that	can	be	gleaned	out	of	this	important	group	of	patients.	These	trends	will	be	further	expanded	upon,	and	depicted	in	the	next	section.			
The	Opioid	Abuse	Triage	Checklist	The	development	of	an	opioid	abuse	triage	checklist	for	Emergency	Departments	requires	reflection	on	the	structure	and	content	of	such	checklist.	The	considerations	when	defining	the	structure	included	specifications	on	certain	aspects	of	the	checklist.	In	order	to	maintain	universality	with	such	a	diagnostic	tool,	I	wanted	to	eliminate	the	need	for	intensive	training	in	order	to	best	utilize	the	checklist.	Thusly,	the	checklist	simply	provides	a	step-by-step	with	a	simple	yes/no	response	required.	The	intention	of	this	simplicity	revolves	around	the	ability	for	
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any	ED	healthcare	provider	to	use	the	tool	in	their	current	workflow	without	any	stoppage	or	interruption.	I	wanted	the	mechanism	to	take	seconds	to	process,	rather	than	minutes.		It	was	important	to	also	determine	where	within	the	Emergency	Department	the	checklist	would	best	be	implemented.	The	two	initial	locations	within	the	process	flow	I	thought	would	be	either	at	the	actual	triage	station	in	the	front	of	the	hospital,	or	at	initial	triage	with	EMTs	bringing	patients	into	the	hospitals.	However,	this	presents	its	own	challenges.	If	placed	at	the	triage	station,	the	checklist	would	miss	patients	with	emergency	issues	brought	in	via	ambulance,	such	as	patients	who	have	attempted	to	complete	suicide,	overdosed,	or	developed	other	acute	issues.	If	instituted	into	the	EMT	plan,	this	would	capture	the	emergency	issues,	but	miss	patients	with	subtler	presentations	of	Opioid	abuse.	Even	the	combination	of	these	two	stations	of	ED	remains	imperfect.	Patients	such	as	the	“Lortab”	patient	cross	the	triage	barrier	with	presentation	as	a	consistent,	acute	migraine.	It’s	only	once	they	reach	a	provider	that	their	insistence	on	medications	indicates	a	potential	opioid	addiction.	This	last	piece	of	information	I	learned	from	my	experience	in	the	ED	set	the	stage	for	this	checklist	to	be	utilized	by	ED	nurses	and	physicians	in	their	processing	of	a	patient	and	their	initial	consult.		In	order	to	easily	create	this	tool,	I	developed	a	suitable	acronym	with	the	key	characteristics	of	the	target	population	in	mind.	The	acronym	DOSES	contains	every	element	discussed	throughout	this	thesis,	and	best	encapsulates	the	“pieces	of	the	puzzle”.	As	referenced	in	Table	1,	if	a	patient	appears	in	the	ED	with	symptoms	of	diseases	of	despair,	they	would	be	checked	off	as	a	high-risk	individual	for	opioid	
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abuse.	When	overviewing	the	patient	history,	if	any	previous	record	of	substance	abuse	or	an	opioid	prescription	by	a	healthcare	provider	appears,	these	patients	would	also	be	tagged.		Next,	within	their	presentation	and	physical	evaluation,	if	the	patient	showcases	with	symptoms	adjacent	to	opioid	abuse,	such	as	needle-stick	infections	or	withdrawal	symptoms,	they	are	a	candidate	targeted	by	the	checklist.	Finally,	the	checklist	also	focuses	on	patients	like	the	“Lortab”	patient	I	interacted	with	at	the	ED—people	who	insist	on	a	particular	medication	with	a	degree	of	animation.			 Table	1:	DOSES	Checklist	Opioid	Abuse	Triage	Checklist	
D	 Diseases	of	Despair	 Patients	who	appear	at	the	ED	either	due	to	liver	failure,	suicide	attempt,	or	overdose.	Important	to	note	history	of	mental	illness.	O	 Opioid	prescriptions	on	record	 Any	history	of	prescribed	opioid	medications.	S	 Symptoms	adjacent	to	opioid	abuse	 History	of	chronic	pain,	needle	stick	infections,	withdrawal	symptoms	E	 Excitement	and	insistence	on	specific	medication(s)	 This	occurs	during	the	actual	patient	visit.		S	 Substance	abuse	history	 Patient	history	indicates	any	history	of	substance	abuse.	Exception	is	tobacco	usage.		 	Finally,	once	the	ED	physicians	and	nurses	detect	and	diagnose	patients	as	potential	opioid	abusers,	the	actual	intervention	and	long-term	treatment	so	desperately	needed	kicks	in.	In	future	studies,	I	believe	that	a	“package”	of	opioid	addiction	education	information	as	well	as	direct	referrals	to	treatment	centers	
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would	set	the	next	step	of	actually	treating,	and	eventually	curing,	patients.	This	ability	to	effectively	detect	and	categorize	patients	would	incentivize	this	process,	as	their	information	could	be	shared	with	referral	centers	for	addiction,	and	an	accountability	system	can	begin	for	each	individual.		A	commonly	used	equation	within	healthcare	finance	and	business	is	the	Healthcare	Value	Equation.	Simply	defined	as	Health	Outcomes/Costs,	the	Value	Equation	provides	a	simple	evaluation	metric	with	which	to	judge	healthcare	interventions	such	as	this	triage	checklist.	I	have	spent	time	providing	evidence	of	the	clinical	implications	of	such	a	checklist,	but	I	would	like	to	highlight	the	financial	side	of	the	intervention	as	well.		The	minimization	of	training	cuts	a	lot	of	administrative	costs	that	otherwise	would	be	put	into	a	complex	checklist.	Additionally,	there	are	no	expensive	tools	or	equipment	that	are	required	for	this	intervention,	cutting	costs	once	again.	The	integration	of	the	checklist	into	the	normal	workflow	of	the	Emergency	Department	also	eliminates	the	need	to	higher	additional	staff	to	conduct	the	intervention,	once	again	minimizing	additional	expenses.	Essentially,	the	only	up-front	costs	of	such	a	checklist	would	be	any	papers	printed	that	would	contain	the	checklist	on	them.	Another	important	source	of	financial	savings	involves	the	long-term	cost	benefits	of	curtailing	future	costly	readmissions	by	opioid	addiction	patients	seeking	further	treatment.	In	summary,	this	intervention	specifically	provides	the	rare	opportunity	in	healthcare	to	combine	both	an	improvement	in	health	outcomes	and	lower	costs.	This	allows	the	overall	calculated	healthcare	value	to	increase	with	sustainable	rates.		
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Limitations		 There	were	limitations	to	this	project	on	both	structural	and	content	levels.	As	I	am	not	a	trained	physician	or	scientist,	my	checklist	does	not	carry	the	same	clinical	or	statistical	power	as	it	would	have	if	I	carried	those	credentials	and	exercised	that	knowledge.	Thus,	the	triage	checklist	cannot	be	used	as	a	diagnostic	tool	when	approaching	patients.	The	use	of	diseases	of	despair,	as	previously	stated,	could	potentially	stereotype	patients	with	serious	and	stigmatized	conditions.	This	in	turn	could	turn	the	checklist	into	a	segregating	tool	for	patients	suffering	from	addiction	and	mental	illnesses—a	currently	vulnerable	population.			 Historically,	the	precedence	of	racializing	a	condition	often	leads	to	the	improper	association	of	the	illness	with	a	specific	demographic.	Even	if	the	current	vulnerable	population	is	seen	as	the	majority,	and	often	the	population	with	the	largest	social	voice,	the	problem	rests	in	creating	a	label	and	placing	it	on	a	demographic.	This	could	lead	to	future	clinical	implications,	influence	a	shift	in	the	demographic	distribution	of	the	condition,	and	other	unforeseen	consequences.			 There	are	also	limitations	set	in	place	for	approaching	the	issue	of	the	Opioid	Epidemic	as	a	patient	problem.	This	simply	focuses	the	direction	of	the	project	on	improving	patient	outcomes,	while	missing	other	viewpoints	in	this	medical	crisis.	By	missing	the	provider	perspective,	an	important	key	of	the	Opioid	Epidemic,	overprescribing,	is	not	analyzed.	There	could	potentially	be	other	pieces	to	this	puzzle	that	are	missing,	because	the	project	simply	focused	on	the	patient.		At	the	end	of	this	checklist,	even	if	it	works	in	effectively	transferring	patients	to	proper	treatment,	the	primary	issue	rests	in	that	there	are	patients	to	
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begin	with.	The	ultimate	problem	in	the	Opioid	Epidemic	is	that	people	are	exposed	to,	and	become	addicted	to,	opioids.	Doctors	continue	to	overprescribe	this	addictive	medication,	and	the	rates	of	addicts	and	overdoses	continue	to	rise.	If	actions	are	not	taken	to	change	the	culture	of	opioid	usage,	and	if	more	effective	methods	of	pain	management	are	not	established	as	protocol,	patients	will	continue	to	need	and	take	opioids	for	their	pain.	Inevitably,	patients	will	then	continue	to	develop	addictions	to	this	medication	that	is	killing	tens	of	thousands,	will	kill	hundreds	of	thousands,	and	has	the	potential	to	continue	to	spread.			
The	Future		 Research	into	this	field	contains	the	potential	to	move	in	a	variety	of	directions.	However,	a	few	key	specific	directions	come	to	my	mind	when	predicting	how	to	maximize	outcomes.	In	order	to	best	complete	the	checklist	and	examine	its	validity,	I	believe	that	a	statistically	significant	population	of	Emergency	Department	healthcare	workers	(nurses,	physicians,	etc.)	should	be	interviewed	on	the	questions	placed	in	the	triage	checklist.	From	the	pooled	answers	of	this	knowledgeable	group,	I	believe	a	cross-analysis	with	the	conclusions	drawn	from	this	paper	would	render	the	checklist	even	more	valid	based	on	large-scale	data	and	research	along	with	personal	accounts	of	realities	within	the	Emergency	Department.	I	recently	acquired	IRB	approval	to	start	this	process,	and	plan	to	continue	to	interview	ED	healthcare	providers	about	their	thoughts	on	opioid	abuse	checklists,	and	this	specific	checklist.		
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A	recent	development	in	my	research	opportunities	opens	up	another	measure	with	which	to	evaluate	my	checklist.	The	Homeless	Health	Initiative	run	by	Dr.	Sheryl	Fleisch	and	Dr.	Mary	Wood	recently	commenced	an	investigation	into	the	data	repository	carried	on	Epic,	which	contains	a	comprehensive	data	bank	on	every	homeless	person	in	Nashville	who	previously	sought	treatment	at	Vanderbilt.	With	this	pool	of	information,	I	can	use	my	checklist	to	screen	this	population	for	opioid	abuse.	Using	a	combination	of	health	records	and	the	checklist,	I	can	determine	how	effective	this	checklist	is	when	collecting	mass	amounts	of	data	on	a	wide	variety	of	patients.	The	code	is	designed	to	be	a	simple	check	for	yes	or	no,	in	the	same	vein	as	the	original	triage	checklist.		Table	2:	Coding	for	DOSES	Checklist	in	Epic	Variable	 Detailed	Instructions	 Response	Options	OA_Rx_Hx	 1. Search	Medication	history	for	any	of	these	known	prescription	opioids	a. Codeine	b. Fentanyl	(Actiq,	Duragesic,	Fentora,	Abstral,	Onsolis)	c. Hydrocodone	(Hysingla,	Zohydro	ER)		d. Hydrocodone/acetaminophen	(Lorcet,	Lortab,	Norco,	Vicodin)	e. Hydromorphone	(Dilaudid,	Exalgo)	f. Meperidine	(Demerol)	g. Morphine	(Kadian,	MS	Contin,	Morphabond)	h. Oxycodone	(OxyContin,	Oxaydo)	i. Oxycodone	and	acetaminophen	(Percocet,	Roxicet)		
0	=	Negative	1	=	Positive					
OA_chron_pain	 1. Chronic	pain	a. Snapshot	problem	list	b. Long-term	pain:	“Leg	pain”	“Back	pain”		c. Exclusion:	short-term	acute	incidents/injuries	
0	=	Negative	1	=	Positive					
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	OA_SUD_Hx	 1. Substance	Use	Hx	a. Any	type	of	abuse	or	dependence	on	the	problem	list	b. Exclude	tobacco	use	c. Search	tab:	substance	listed	
0	=	Negative	1	=	Positive				
OA_Sec_Sx	 1. Secondary	symptoms	a. Infection		b. Search	terms:	needle,	infection,	detox,	withdrawal,	overdose,	MRSA	
0	=	Negative	1	=	Positive				OA_DoD	 1. Disease	of	Despair	a. Depression,	Anxiety	 0	=	Negative	1	=	Present		OA_Add_Dep	 1. Opioid	Use	Dependence/Addictionà	within	the	chart	 0	=	Negative	1	=	Present			 Once	the	triage	checklist	for	opioid	abuse	and	addiction	has	been	assessed	both	at	a	patient	and	provider	level,	the	next	step	would	be	to	implement	the	tool	in	various	Emergency	Departments	in	high-density	patient	populations.	If	shown	more	effective	in	a	side-by-side	comparison	with	the	current	standard	of	care,	it	would	support	the	hypothesis	that	triage	checklists	improve	health	outcomes	for	patients	suffering	from	opioid-centric	diseases	of	despair.	Due	to	the	currently	immense	clinical	need	for	improved	methods	of	care	for	patients	suffering	from	opioid	abuse	and	addiction,	this	project’s	latent	impact	lays	heavy.	The	simplicity	of	the	process,	the	ability	to	objectively	measure	an	outcome	(time	to	disposition),	and	the	intense	national	desire	to	see	dramatic	improvement	in	the	public	health’s	management	of	this	Epidemic	lend	this	checklist	immense	potential.	My	passion	for	this	cause	and	the	stated	clinical	importance	of	such	an	intervention	lead	me	to	a	desire	to	continue	to	pursue	the	validity	and	efficacy	of	this	checklist	in	my	future	academic	and	clinical	endeavors.		
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